Health Trials

Pulmonary TB

2

Review clinical trials related to Pulmonary TB. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease

RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority trial to compare the 6-month standard treatment for DS-TB with a 4-month optimised- rifampicin based regimen provided to individuals with limited disease severity.

Participants needed: 1,000
Trial details
Phase: Phase 3Age: 12+Biological sex: AllType: InterventionalSponsor: Hamilton Health Sciences CorporationUpdated: Aug 12, 2025
Eligibility criteria

Aged 12 years and over [+5]

Received more than 7 days treatment for index TB episode [+14]

Read more
Status: Recruiting

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung function, and chest CT findings, which will aid in the development of prognostic and therapeutic strategies for PTLD.

Participants needed: 400
Trial details
Age: 25-60Biological sex: MaleType: ObservationalSponsor: Peking University Third HospitalUpdated: Jun 22, 2022Locations: 2
Eligibility criteria

patients with positive sputum smear or TB culture results; [+5]

Read more